title: Proportion of deproteinized bovine bone and autogenous bone affects bone formation in the treatment of calvarial defects in rabbits.
abstract: This study assessed new bone formation generated using three different proportions of autogenous bone (AB) and deproteinized bovine bone (DBB). Thirty bicortical skull defects were prepared in 15 rabbits, divided into 3 groups: Group 1, critical size defect (CSD) versus AB as controls; Group 2, DBB versus a composite of AB and DBB using a proportion of 1:1; and Group 3, a composite of AB and DBB using a proportion of 1:2 versus a proportion of 1:4. After 8 weeks, radiographic evaluation was assessed using densitometry and new bone formation by histomorphometry. The mean optical density of the CSD (0.108+/-0.238) and AB (0.352+/-0.161) groups differed significantly from the DBB group (1.044+/-0.093) and the groups using a proportion of 1:1 (0.905+/-0.078), 1:2 (0.865+/-0.294) and 1:4 (0.867+/-0.304). Histomorphometry revealed a higher percentage of new bone in the AB group (30.223+/-16.722) than in the groups using proportions of 1:2 (22.639+/-5.659), 1:1 (20.929+/-6.169), 1:4 (9.621+/-2.400), DBB (14.441+/-2.742) and CSD (10.645+/-8.868), respectively. The 1:2 group had significantly higher bone content than the 1:4 group. The proportions of 1:1 and 1:2 resulted in greater bone formation than the proportion of 1:4, DBB and CSD.
authors.affiliation: Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Prince of Songkla University, Hatyai, Songkhla, 90112, Thailand. prisana.p@psu.ac.th
authors.forename: P
authors.initials: P
authors.lastname: Pripatnanont
authors.forename: T
authors.initials: T
authors.lastname: Nuntanaranont
authors.forename: S
authors.initials: S
authors.lastname: Vongvatcharanon
mesh_terms: D000818:Animals; D001672:Biocompatible Materials / Q000737:chemistry* / Q000627:therapeutic use; D001857:Bone Matrix / Q000737:chemistry* / Q000637:transplantation; D001861:Bone Regeneration / Q000187:drug effects*; D018786:Bone Substitutes / Q000737:chemistry* / Q000627:therapeutic use; D016025:Bone Transplantation / Q000379:methods; D002417:Cattle; D003399:Craniotomy; D004338:Drug Combinations; D008297:Male; D016348:Osseointegration / Q000187:drug effects*; D011817:Rabbits; D012886:Skull / Q000033:anatomy & histology / Q000187:drug effects / Q000601:surgery
chemical_list: D001672:Biocompatible Materials; D018786:Bone Substitutes; D004338:Drug Combinations